Medical Cannabis Prescription in Norway

NorwayProgram Active

Guide to medical cannabis in Norway. Learn about the named-patient permit system, Sativex availability, costs, and how to access medical cannabis through specialist physicians.

View all European medical cannabis guides →Medical cannabis conditions →

Program Details

Average Cost

NOK 150–300/g (~€13–€26)

Year Established

2016

Prescription

Required

InsuranceNot Covered

Online ConsultNot Available

Pharmacy AccessAvailable

Program StatusActive

Overview

Norway allows medical cannabis access primarily through named-patient permits (godkjenningsfritak) issued by the Norwegian Medicines Agency (Legemiddelverket). Sativex is the only cannabis-based medicine with standard marketing authorization in Norway, approved for MS spasticity. For other conditions, doctors must apply for individual patient permits.

Norway’s approach to medical cannabis is conservative, reflecting its traditionally strict drug policy. Access is limited, costs are high, and the named-patient permit process adds administrative burden. However, there is growing public and political support for expanding access, particularly for chronic pain patients.

Key Facts

•Sativex is the only cannabis medicine with marketing authorization in Norway, approved for MS spasticity.
•All other cannabis products require a named-patient permit (godkjenningsfritak) from Legemiddelverket.
•Medical cannabis costs are generally not covered by Norway’s national insurance scheme.
•Hospital-based specialists are the primary prescribers — GP prescriptions are uncommon.
•Norway is evaluating potential reforms to its medical cannabis access framework.

How to Get a Prescription: Step-by-Step

1Consult a specialist physician at a hospital. Medical cannabis prescriptions in Norway typically originate from hospital-based specialists.

2The specialist evaluates your condition and confirms that all standard treatments have been tried and have failed. Thorough documentation is required.

3The specialist applies to the Norwegian Medicines Agency (Legemiddelverket) for a named-patient permit (godkjenningsfritak) to prescribe an unlicensed cannabis product.

4Once the permit is granted, the specialist issues a prescription. Sativex is available without a special permit for MS spasticity.

5Fill the prescription at a hospital or community pharmacy. Costs are not covered by the national insurance scheme for most patients.

Qualifying Conditions

+Multiple sclerosis spasticity

+Chronic pain (case-by-case)

+Chemotherapy-induced nausea (case-by-case)

+Treatment-resistant epilepsy (case-by-case)

Frequently Asked Questions

Can my GP prescribe medical cannabis in Norway?+

While technically possible, it is uncommon. Most medical cannabis prescriptions in Norway come from hospital-based specialists who have the expertise and authority to apply for named-patient permits from the Medicines Agency.

Is Sativex available in Norway?+

Yes, Sativex (nabiximols) has marketing authorization in Norway for the treatment of MS-related spasticity. It can be prescribed by any doctor without the need for a named-patient permit.

How long does the named-patient permit process take in Norway?+

The permit process typically takes 1–3 weeks. The specialist submits an application to Legemiddelverket, which reviews the medical justification before granting permission.

Medical Cannabis in Other European Countries

Explore medical cannabis prescription guides for other European countries with active programs.

Denmark

Est. 2018

DKK 50–150/day (~€7–€20/day)

Continue Exploring

All Countries

European medical index

US Medical Cards

State-by-state guides

Medical Cannabis

Conditions & treatments

Legalization Tracker

Laws worldwide

Disclaimer: The information on this page is provided for educational and informational purposes only and does not constitute medical or legal advice. Cannabis laws and medical programs in Norway are subject to change. Always verify current requirements with Norway's official health authority and consult with a qualified health care provider before pursuing medical cannabis treatment. Cannabismarketcap does not guarantee the accuracy or completeness of any information presented.